[HTML][HTML] Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open …

D Azzopardi, NJ Robertson, A Bainbridge… - The Lancet …, 2016 - thelancet.com
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label …

D Azzopardi, NJ Robertson, A Bainbridge… - The Lancet …, 2015 - europepmc.org
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label …

D Azzopardi, NJ Robertson, A Bainbridge… - Lancet …, 2016 - research.ed.ac.uk
BACKGROUND: Moderate cooling after birth asphyxia is associated with substantial
reductions in death and disability, but additional therapies might provide further benefit. We …

[PDF][PDF] Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label …

D Azzopardi, NJ Robertson, A Bainbridge, E Cady… - kclpure.kcl.ac.uk
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label …

D Azzopardi, NJ Robertson, A Bainbridge… - The Lancet …, 2016 - escholarship.org
BackgroundModerate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label …

D Azzopardi, NJ Robertson, A Bainbridge, E Cady… - 2016 - pubmed.ncbi.nlm.nih.gov
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

[PDF][PDF] Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe)

D Azzopardi, NJ Robertson, A Bainbridge… - Lancet …, 2016 - pure-oai.bham.ac.uk
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

[HTML][HTML] Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open …

D Azzopardi, NJ Robertson, A Bainbridge… - The Lancet …, 2016 - ncbi.nlm.nih.gov
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

[PDF][PDF] Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe)

D Azzopardi, NJ Robertson, A Bainbridge, E Cady… - Lancet Neurol, 2016 - core.ac.uk
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …

[HTML][HTML] Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open …

D Azzopardi, NJ Robertson, A Bainbridge, E Cady… - The Lancet …, 2016 - Elsevier
Background Moderate cooling after birth asphyxia is associated with substantial reductions
in death and disability, but additional therapies might provide further benefit. We assessed …